Enliven Therapeutics (ELVN) News Today $22.45 -0.33 (-1.45%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$22.45 0.00 (0.00%) As of 07/11/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ELVN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Enliven Therapeutics Breaks Above 200-Day Moving Average - NasdaqJuly 12 at 10:02 AM | nasdaq.comEnliven Therapeutics, Inc. (NASDAQ:ELVN) Receives Average Rating of "Buy" from BrokeragesJuly 11 at 4:23 AM | americanbankingnews.comEnliven Therapeutics, Inc. (NASDAQ:ELVN) Receives Average Recommendation of "Buy" from BrokeragesJuly 11 at 4:20 AM | marketbeat.comEnliven Therapeutics, Inc. (NASDAQ:ELVN) COO Anish Patel Sells 6,667 SharesJuly 9, 2025 | marketbeat.comEnliven Therapeutics (NASDAQ:ELVN) Trading 5.4% Higher - What's Next?July 9, 2025 | marketbeat.comHC Wainwright Issues Optimistic Outlook for ELVN EarningsJuly 5, 2025 | americanbankingnews.comQ2 EPS Forecast for Enliven Therapeutics Boosted by AnalystJuly 4, 2025 | marketbeat.comEnliven Therapeutics (NASDAQ:ELVN) Given New $48.00 Price Target at HC WainwrightJuly 4, 2025 | americanbankingnews.comEnliven Therapeutics (NASDAQ:ELVN) Trading 7.9% Higher Following Analyst UpgradeJuly 4, 2025 | americanbankingnews.comEnliven Therapeutics (NASDAQ:ELVN) Shares Up 7.9% Following Analyst UpgradeJuly 2, 2025 | marketbeat.comEnliven Therapeutics (NASDAQ:ELVN) Stock Price Expected to Rise, HC Wainwright Analyst SaysJuly 2, 2025 | marketbeat.comBenjamin Hohl Sells 3,250 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) StockJuly 2, 2025 | insidertrades.comEnliven Therapeutics, Inc. (NASDAQ:ELVN) CFO Benjamin Hohl Sells 3,250 SharesJuly 1, 2025 | marketbeat.comEnliven Therapeutics’ Promising CML Study: A Potential Game-Changer?June 30, 2025 | tipranks.comInsider Selling: Enliven Therapeutics, Inc. (NASDAQ:ELVN) Insider Sells 12,500 Shares of StockJune 24, 2025 | marketbeat.comEnliven Short Interest Falls To 14-Month Low After Leukemia Trial Data, Goldman Initiates With ‘Buy’June 23, 2025 | msn.comEnliven Therapeutics, Inc. (NASDAQ:ELVN) CEO Sells $277,250.00 in StockJune 18, 2025 | marketbeat.comGoldman Sachs initiates Enliven Therapeutics stock with Buy ratingJune 17, 2025 | investing.comEnliven Therapeutics, Inc. (ELVN) Backed by Goldman Sachs After Strong Trial DataJune 17, 2025 | msn.comEnliven Therapeutics Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional SharesJune 16, 2025 | prnewswire.comEnliven Therapeutics (NASDAQ:ELVN) Shares Gap Up Following Analyst UpgradeJune 16, 2025 | marketbeat.comEnliven Therapeutics, Inc. (NASDAQ:ELVN) Receives Consensus Rating of "Buy" from AnalystsJune 16, 2025 | marketbeat.comRobert W. Baird Issues Positive Forecast for Enliven Therapeutics (NASDAQ:ELVN) Stock PriceJune 16, 2025 | marketbeat.comEnliven Therapeutics (NASDAQ:ELVN) Coverage Initiated by Analysts at The Goldman Sachs GroupJune 16, 2025 | marketbeat.comEnliven Therapeutics Announces $200 Mln Offering Of Common Stock, Pre-Funded WarrantsJune 15, 2025 | nasdaq.comEnliven Therapeutics stock falls after pricing capital raise of $200M via securities offeringJune 13, 2025 | msn.comEnliven Therapeutics (NASDAQ:ELVN) Shares Gap Down - Should You Sell?June 13, 2025 | marketbeat.comEnliven Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded WarrantsJune 13, 2025 | prnewswire.comEnliven Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsJune 13, 2025 | prnewswire.comEnliven Therapeutics Announces Updated Positive Data from Phase 1 Clinical Trial of ELVN-001 in CML at EHA 2025 CongressJune 13, 2025 | prnewswire.comInsider Selling: Enliven Therapeutics, Inc. (NASDAQ:ELVN) COO Sells 6,667 Shares of StockJune 11, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $984,000 Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN)June 11, 2025 | marketbeat.comEnliven Therapeutics (NASDAQ:ELVN) Stock Price Up 7.1% - Time to Buy?June 10, 2025 | marketbeat.comBank of America Corp DE Sells 14,504 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN)June 9, 2025 | marketbeat.comEnliven Therapeutics (NASDAQ:ELVN) Stock Price Down 4% on Insider SellingJune 6, 2025 | marketbeat.comEnliven Therapeutics, Inc. (NASDAQ:ELVN) Insider Sells 7,500 SharesJune 6, 2025 | insidertrades.comInsider Selling: Enliven Therapeutics, Inc. (NASDAQ:ELVN) Insider Sells 7,500 Shares of StockJune 5, 2025 | marketbeat.comInsider Selling: Enliven Therapeutics, Inc. (NASDAQ:ELVN) CEO Sells 7,500 Shares of StockJune 5, 2025 | marketbeat.comMillennium Management LLC Buys 26,449 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN)June 5, 2025 | marketbeat.comAmeriprise Financial Inc. Invests $789,000 in Enliven Therapeutics, Inc. (NASDAQ:ELVN)June 3, 2025 | marketbeat.comWhat is Lifesci Capital's Forecast for ELVN FY2025 Earnings?June 2, 2025 | marketbeat.comBrokers Set Expectations for ELVN Q2 EarningsMay 31, 2025 | marketbeat.comEnliven Therapeutics (NASDAQ:ELVN) Stock Price Up 6.2% - Should You Buy?May 30, 2025 | marketbeat.comEnliven Therapeutics, Inc. (NASDAQ:ELVN) Given Consensus Recommendation of "Buy" by AnalystsMay 24, 2025 | marketbeat.comEnliven Therapeutics to Present at Upcoming Investor ConferencesMay 22, 2025 | prnewswire.comEnliven Therapeutics, Inc. (NASDAQ:ELVN) Insider Sells $81,550.00 in StockMay 22, 2025 | insidertrades.comEnliven Therapeutics, Inc. (NASDAQ:ELVN) Shares Purchased by Northern Trust CorpMay 22, 2025 | marketbeat.comSoleus Capital Management L.P. Has $1.70 Million Position in Enliven Therapeutics, Inc. (NASDAQ:ELVN)May 21, 2025 | marketbeat.comHC Wainwright Issues Pessimistic Outlook for ELVN EarningsMay 20, 2025 | marketbeat.comPolar Capital Holdings Plc Acquires 1,739,668 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN)May 17, 2025 | marketbeat.com Get Enliven Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ELVN and its competitors with MarketBeat's FREE daily newsletter. Email Address ELVN Media Mentions By Week ELVN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ELVN News Sentiment▼0.511.01▲Average Medical News Sentiment ELVN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ELVN Articles This Week▼74▲ELVN Articles Average Week Get Enliven Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ELVN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Zai Lab News Today PTC Therapeutics News Today Ultragenyx Pharmaceutical News Today Ascentage Pharma Group International News Today Merus News Today Arcellx News Today SpringWorks Therapeutics News Today Avidity Biosciences News Today ACADIA Pharmaceuticals News Today Scholar Rock News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ELVN) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enliven Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enliven Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ELVN Stock Alerts